In line with these data, in our study, afamin levels were found to be 32.2% higher in the NDO group and nearly two-fold higher in the T2DM group, suggesting that elevated afamin may indicate metabolic disturbance in severe obesity with intact glucose parameters. The gene discussed is AFM; the disease is Obesity.